Cellartis

Cellartis Participates in Pioneering Stem Cell Collaboration in Scotland

Thu, Jan 18, 2007 12:00 CET

New World-Leading R&D Centre Set Up in DundeeGOTHENBURG, January 18, 2007. The Gothenburg, Sweden, based biotech company Cellartis AB and its partners ITI Life Sciences and University of Glasgow today announced an extensive £9.5 million R&D programme to develop human stem cells for pharmaceutical research. The funding of the programme was made by ITI Life Sciences.“This is an immensely exciting programme, and we are very much looking forward to participating in it. This important collaboration is in line with our strategic goal of scaling up our human embryonic stem cell technology”,

Scotland Moves Another Step Closer to Global Leadership in Stem Cell Research

Thu, Jan 18, 2007 12:00 CET

ITI Life Sciences Initiates £9.5 million R&D Programme to Develop Human Stem Cells for Pharmaceutical Research with University of Glasgow and Swedish biotech company Cellartis ABScotland today took another step closer to global leadership in stem cell research with the launch of a new £9.5 million R&D programme by ITI Life Sciences (Dundee, Scotland) to develop an automated process to produce high-quality human stem cells. This capability does not exist anywhere in the world and its development will put Scotland at the forefront of stem cell research as well as bringing closer the use of

Cellartis AB Raises € 8 Million for the Development of Human Functional Cells

Tue, Dec 13, 2005 06:00 CET

BioFund New Shareholder in the Innovative Stem Cell CompanyGOTHENBURG, SWEDEN. Cellartis AB is pleased to announce the successful completion of a financing round led by a new investor, Bio Fund Management Ltd of Finland (BioFund). Existing shareholders, InnovationsKapital, Catella Healthcare Investments, T-bolaget, Texcel and Barnwik AB, also participated in the financing round. “The financing will allow Cellartis to accelerate the development of different human cell types for use in drug discovery, as well as toxicological testing, and generate GMP grade cells in large quantities necessary